Table 2.
Clinical outcomes and temporal trends.
Event Rate | ||||
---|---|---|---|---|
Event | Overall | 0–30 days | Month 1–12 | 12 month – 4 year |
ISCHEMIC ENDPOINT | ||||
Cardiovascular death, non-periprocedural myocardial infarction or definite/probable stent thrombosis | 1.64%/yr 0.14%/mo (6.51%)* |
10.76%/yr 0.90%/mo (0.89%)* |
1.42%/yr 0.12%/mo (1.29%)* |
1.44%/yr 0.12%/mo (4.40%)* |
Cardiovascular death | 0.91%/yr 0.08%/mo (3.69%) |
5.24%/yr 0.44%/mo (0.44%)* |
0.82%/yr 0.07%/mo (0.75%)* |
0.88%/yr 0.07%/mo (2.72%)* |
Non-periprocedural myocardial infarction | 0.87%/yr 0.07%/mo (3.52%)* |
5.24%/yr 0.44%/mo (0.44%)* |
1.10%/yr 0.09%/mo (1.00%)* |
0.69%/yr 0.06%/mo (2.11%)* |
Definite/probable stent thrombosis | 0.51%/yr 0.04%/mo (2.06%)* |
|||
Acute | 34.45%/yr 2.87%/mo (0.10%)* |
N/A | N/A | |
Subacute | 8.47%/yr 0.71%/mo (0.68%)* |
N/A | N/A | |
Late | N/A | 0.31%/yr 0.03%/mo (0.29%)* |
N/A | |
Very late | N/A | N/A | 0.37%/yr 0.03%/mo (1.14%)* |
|
BLEEDING ENDPOINT | ||||
GUSTO Moderate/Severe bleeding | 0.75%/yr 0.06%/mo (3.03%)* |
8.19%/yr 0.68%/mo (0.68%)* |
1.08%/yr 0.09%/mo (0.98%)* |
0.44%/yr 0.04%/mo (1.36%)* |
Moderate | 0.40%/yr 0.03%/mo (1.64%)* |
2.94%/yr 0.24%/mo (0.24%)* |
0.64%/yr 0.05%/mo (0.59%)* |
0.26%/yr 0.02%/mo (0.82%)* |
Severe | 0.34%/yr 0.03%/mo (1.39%)* |
5.24%/yr 0.44%/mo (0.44%)* |
0.57%/yr 0.05%/mo (0.52%)* |
0.17%/yr 0.01%/mo (0.54%)* |
Absolute rate